With many Regeneron and Lilly antibodies going unused, new candidates aim to ease dosing and defeat variants

With many Regeneron and Lilly antibodies going unused, new candidates aim to ease dosing and defeat variants
esagonowsky
Thu, 01/21/2021 – 09:19